Literature DB >> 11070000

Role of Vif in stability of the human immunodeficiency virus type 1 core.

A Ohagen1, D Gabuzda.   

Abstract

The Vif protein of human immunodeficiency virus type 1 (HIV-1) is important for virion infectivity. Previous studies have shown that vif-defective virions exhibit structural abnormalities in the virus core and are defective in the ability to complete proviral DNA synthesis in acutely infected cells. We developed novel assays to assess the relative stability of the core in HIV-1 virions. Using these assays, we examined the role of Vif in the stability of the HIV-1 core. The integrity of the core was examined following virion permeabilization or removal of the lipid envelope and treatment with various triggers, including S100 cytosol, deoxynucleoside triphosphates, detergents, NaCl, and buffers of different pH to mimic aspects of the uncoating and disassembly process which occurs after virus entry but preceding or during reverse transcription. vif mutant cores were more sensitive to disruption by all triggers tested than wild-type cores, as determined by endogenous reverse transcriptase (RT) assays, biochemical analyses, and electron microscopy. RT and the p7 nucleocapsid protein were released more readily from vif mutant virions than from wild-type virions, suggesting that the internal nucleocapsid is less stably packaged in the absence of Vif. Purified cores could be isolated from wild-type but not vif mutant virions by sedimentation through detergent-treated gradients. These results demonstrate that Vif increases the stability of virion cores. This may permit efficient viral DNA synthesis by preventing premature degradation or disassembly of viral nucleoprotein complexes during early events after virus entry.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070000      PMCID: PMC113185          DOI: 10.1128/jvi.74.23.11055-11066.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.

Authors:  T Fitzon; B Leschonsky; K Bieler; C Paulus; J Schröder; H Wolf; R Wagner
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

2.  Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

Authors:  J Sodroski; W C Goh; C Rosen; A Tartar; D Portetelle; A Burny; W Haseltine
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

3.  Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription.

Authors:  G Dornadula; S Yang; R J Pomerantz; H Zhang
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.

Authors:  R Welker; H Hohenberg; U Tessmer; C Huckhagel; H G Kräusslich
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Two species of full-length cDNA are synthesized in high yield by melittin-treated avian retrovirus particles.

Authors:  L R Boone; A Skalka
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

6.  Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.

Authors:  H Zhang; R J Pomerantz; G Dornadula; Y Sun
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag).

Authors:  M A Accola; A Ohagen; H G Göttlinger
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes.

Authors:  J H Simon; E A Carpenter; R A Fouchier; M H Malim
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Association of Nef with the human immunodeficiency virus type 1 core.

Authors:  A Kotov; J Zhou; P Flicker; C Aiken
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

10.  Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.

Authors:  M Dettenhofer; X F Yu
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more
  31 in total

1.  Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.

Authors:  P Sova; D J Volsky; L Wang; W Chao
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.

Authors:  Reynel Cancio; Silvio Spadari; Giovanni Maga
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

3.  RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.

Authors:  Amanda Roa; Fumiaki Hayashi; Yang Yang; Maritza Lienlaf; Jing Zhou; Jiong Shi; Satoru Watanabe; Takanori Kigawa; Shigeyuki Yokoyama; Christopher Aiken; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

4.  A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly.

Authors:  Takanori Hori; Hiroaki Takeuchi; Hideki Saito; Ryuta Sakuma; Yoshio Inagaki; Shoji Yamaoka
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

5.  Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity in vivo.

Authors:  Bjarki Gudmundsson; Stefán Ragnar Jónsson; Oddur Olafsson; Gudrún Agnarsdóttir; Sigrídur Matthíasdóttir; Gudmundur Georgsson; Sigurbjorg Torsteinsdóttir; Vilhjálmur Svansson; Helga Bryndís Kristbjornsdóttir; Sigrídur Rut Franzdóttir; Olafur S Andrésson; Valgerdur Andrésdóttir
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Inhibition of reverse transcriptase activity increases stability of the HIV-1 core.

Authors:  Yang Yang; Thomas Fricke; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 7.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

8.  HIV-1 Vif and APOBEC3G: multiple roads to one goal.

Authors:  Joao Goncalves; Mariana Santa-Marta
Journal:  Retrovirology       Date:  2004-09-21       Impact factor: 4.602

9.  The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.

Authors:  Sandra Kao; Mohammad A Khan; Eri Miyagi; Ron Plishka; Alicia Buckler-White; Klaus Strebel
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase.

Authors:  Alexandra Kataropoulou; Chiara Bovolenta; Amalia Belfiore; Sonia Trabatti; Anna Garbelli; Simona Porcellini; Rossella Lupo; Giovanni Maga
Journal:  Nucleic Acids Res       Date:  2009-04-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.